# Budesonide Application Via Mucosal Atomization Device as a Treatment for Chronic Rhinosinusitis When Utilized as a Topical Nasal Steroid Spray

> **NCT01405339** · PHASE1,PHASE2 · COMPLETED · sponsor: **St. Paul's Hospital, Canada** · enrollment: 20 (actual)

## Conditions studied

- Chronic Rhinosinusitis

## Interventions

- **DEVICE:** Mucosal Atomization Device (MAD)
- **DEVICE:** Budesonide via Nasal Syringe

## Key facts

- **NCT ID:** NCT01405339
- **Lead sponsor:** St. Paul's Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-05
- **Final completion:** 2014-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01405339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01405339, "Budesonide Application Via Mucosal Atomization Device as a Treatment for Chronic Rhinosinusitis When Utilized as a Topical Nasal Steroid Spray". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01405339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*